Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells

@article{McAllister2007CannabidiolAA,
  title={Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells},
  author={Sean D McAllister and Rigel T. Christian and Maxx P. Horowitz and Amaia Garcia and Pierre-Yves Desprez},
  journal={Molecular Cancer Therapeutics},
  year={2007},
  volume={6},
  pages={2921 - 2927}
}
Invasion and metastasis of aggressive breast cancer cells is the final and fatal step during cancer progression, and is the least understood genetically. Clinically, there are still limited therapeutic interventions for aggressive and metastatic breast cancers available. Clearly, effective and nontoxic therapies are urgently required. Id-1, an inhibitor of basic helix-loop-helix transcription factors, has recently been shown to be a key regulator of the metastatic potential of breast and… 
View on AACR
letfreedomgrow.com
192 Citations
Highly Influential Citations
16
Background Citations
91
Methods Citations
8
Results Citations
7

Figures and Tables from this paper

192 Citations

Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis

It is shown that CBD inhibits human breast cancer cell proliferation and invasion through differential modulation of the extracellular signal-regulated kinase (ERK) and reactive oxygen species (ROS) pathways, and that both pathways lead to down-regulation of Id-1 expression.

Cannabidiol Treatment Results in a Common Gene Expression Response Across Aggressive Cancer Cells from Various Origins.

This study confirmed that ID1 was a major target downregulated by CBD and also discovered that CBD inhibited FOXM1 (Forkhead box M1), a transcriptional activator involved in cell proliferation, while simultaneously upregulating GDF15 (growth differentiation factor 15), a cytokine associated with tissue differentiation.

Abstract 5308: Id-1 gene and protein as novel therapeutic targets for metastatic cancer

It is shown that reduction of Id-1 levels, and consequently MMP expression, could significantly decrease the metastatic spread of cancer cells and suggested that Id proteins act as key regulators of tumor metastasis.

Cannabinoids: a new hope for breast cancer therapy?

Aggressiveness and a Novel Therapeutic Target Id-1 Is a Key Transcriptional Regulator of Glioblastoma

It is shown that the transcriptional regulator Id-1 plays a critical role in modulating the invasiveness of glioblastoma cell lines and primary gli oblastoma cells, and that drugs targeting Id- 1 represent a novel and promising strategy for improving the therapy and outcome of patients with gliOBlastoma.

Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells.

Results obtained here demonstrated that cannabidiolic acid had dual inhibitory effects on COX-2 through down-regulation and enzyme inhibition, and CBDA may possess the ability to suppress genes that are positively involved in the metastasis of cancer cells in vitro.

Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target.

It is shown that the transcriptional regulator Id-1 plays a critical role in modulating the invasiveness of glioblastoma cell lines and primary gliablastoma cells, and that drugs targeting Id- 1 represent a novel and promising strategy for improving the therapy and outcome of patients with gliOBlastoma.

Regulation of Id-1 Gene Expression in Aggressive Breast Cancer and Glioblastoma Cells Using Cannabinoid Compounds

This study shows that Id-1 downregulation strongly correlates with a reduced tumor aggressiveness and thatId-1 might represent a potent therapeutic target for breast cancer and glioblastoma.

Molecular and Cellular Pathobiology Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target

It is shown that the transcriptional regulator Id-1 plays a critical role in modulating the invasiveness of glioblastoma cell lines and primary gli oblastoma cells, and that drugs targeting Id- 1 represent a novel and promising strategy for improving the therapy and outcome of patients with gliOBlastoma.

The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies

This review focuses on the current status of investigations on the impact of inhibitors of endocannabinoid-degrading enzymes on tumour growth and spread in preclinical oncology research and provides an overview of the regulation of the endoc cannabinoidoid system in cancer.
...

References

SHOWING 1-10 OF 34 REFERENCES

aggressive breast cancer cells Cannabidiol as a novel inhibitor of Id-1 gene expression in Updated

CBD represents the first nontoxic exogenous agent that can significantly decrease Id-1 expression in metastatic breast cancer cells leading to the down-regulation of tumor aggressiveness.

Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis

  • S. FongY. Itahana P. Desprez
  • Biology, Medicine
    Proceedings of the National Academy of Sciences of the United States of America
  • 2003
It is shown that human metastatic breast cancer cells become significantly less invasive in vitro and less metastatic in vivo when Id-1 is down-regulated by stable transduction with antisense Id-2, suggesting a potential mechanism for the reduction of invasiveness.

A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.

The results suggest that Id-1 can control the malignant progression of breast cancer cells, particularly that mediated by sex steroid hormones, and has the potential to serve as a marker for aggressive breast tumors.

The multiple roles of Id-1 in cancer progression.

In prostate cancer cells, expression of Id-1 was able to activate EGF-R and nuclear factor-kappaB activities and resulted in progression to androgen independence and in both nasopharyngeal carcinoma and prostate cancer Cells, Id- 1 expression was found to protect the cells from chemotherapeutic drug-induced apoptosis through regulation of the Raf-1/MAPK and JNK pathways.

Id genes and proteins as promising targets in cancer therapy.

A Novel Pathway for Mammary Epithelial Cell Invasion Induced by the Helix-Loop-Helix Protein Id-1

It is suggested that Id-1 controls invasion by normal and neoplastic mammary epithelial cells, primarily through induction of a ∼120-kDa gelatinase, which could contribute to involution of the mammary gland and possibly to the development of invasive breast cancer.

Molecular markers of metastasis in breast cancer: current understanding and prospects for novel diagnosis and prevention

The early and clinically occult spread of viable tumour cells throughout the body is increasingly considered as a hallmark of cancer progression, because recent data suggest that these cells are…

Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells

It is discovered that Δ9-THC decreases cell proliferation and increases cell death of human GBM cells more rapidly than WIN 55,212-2 and was also more potent at inhibiting the proliferation of G BM cells compared to WIN55,212,2.

Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

It is shown that intratumoral administration of Δ9-tetrahydrocannabinol and the synthetic cannabinoid agonist WIN-55,212-2 induced a considerable regression of malignant gliomas in Wistar rats and in mice deficient in recombination activating gene 2.

Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22phox and Nox4 Expression

The results from this study reveal that cannabidiol, acting through CB2 and regulation of Nox4 and p22phox expression, may be a novel and highly selective treatment for leukemia.